Please assess the completion status of the following clinical trial:

Trial Title: Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Are at least 21 years old, and~* Have Stage 1 high blood pressure. (Defined as a systolic blood pressure between 140 mm Hg and 159 mm Hg (the top blood pressure number) and/or a diastolic blood pressure between 90 mm Hg and 99 mm Hg (the bottom blood pressure number) in the prior 6 months.)~Exclusion Criteria:~* Take drugs to control blood pressure.~* Have a history of left ventricular hypertrophy.~* Have a history of cardiovascular disease such as stroke, mini-strokes, heart attack, unstable angina, bypass surgery, stents, angioplasty, abnormal heart rhythms, heart failure, or peripheral artery disease.~* Have diabetes.~* Have a history of poor kidney function.~* Have an upper arm circumference greater than 17 inches.~* Are currently participating in a formal exercise or weight loss program.~* Plan to participate in a formal exercise or weight loss program in the next 6 months.~* Are pregnant or plan to become pregnant in the next 6 months.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Device Guided Breathing/Combination Therapy (Type: ACTIVE_COMPARATOR): Participants will first do device guided breathing for 8 weeks, followed by 8 weeks of doing BOTH the device guided breathing AND the hand grip exercises. Participants will be given a home blood pressure monitor. Participants will measure blood pressure and heart rate at home for 2 weeks prior to starting any intervention and also during the 16 week of intervention.
- Isometric Hand Grip/Combination Therapy (Type: ACTIVE_COMPARATOR): Participants will first do isometric hand grip exercises for 8 weeks, followed by 8 weeks of doing BOTH the device guided breathing AND the hand grip exercises. Participants will be given a home blood pressure monitor. Participants will measure blood pressure and heart rate at home for 2 weeks prior to starting any intervention and also during the 16 week of intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).